Collusion
Collusion
From Kompas
The Indonesian Medical Association governing board's general
chairman, Dr. Merdias Almatsier SpS (K), has been quoted recently
in a number of mass media publications as attributing the
difficulty in taking action against certain physicians involved
in collusion with pharmaceutical companies to insufficient
evidence.
Let me now inquire, what kind of evidence is needed to bring
to court physicians colluding with pharmaceutical companies? Will
the evidence be money transfer slips sent to a certain
physicians? Or "taking" to court pharmaceutical companies
involved in profit-sharing businesses with a number of
physicians? The collusion between certain physicians and
pharmaceutical companies has disadvantaged consumers (patients).
The cost of collusion is added to the price of each pill that
a patient takes. This means augmenting the profit of the
pharmaceutical companies and hampering the government program to
popularize the use of generic medicines.
If the chairman has the guts and high idealism to take action
against certain physicians colluding with a pharmaceutical
company located in East Jakarta, I'm willing to provide him with
a number of authentic pieces of evidence of bank transfers and a
list of certain physicians' bank account numbers in a number of
major cities in Indonesia. Or, if there are, perhaps, some non-
governmental organizations really intent on filing a class action
in the interest of the community, I'll be ready to provide them
with relevant evidence.
GANI
Tangerang, West Java
Source: jawawa.id (https://jawawa.id/newsitem/collusion-1447899208-1397380)
Originally published by The Jakarta Post